N-(3-iodoprop-2E-enyl)-2 beta-carbomethoxy-3 beta-(4'-methyl phenyl) nortropane as a selective marker for the dopamine transporter: Validation in a rat model of Parkinson's disease.

被引：0

作者：

Chalon, S

Emond, P

Thiercelin, C

Bodard, S

Garreau, L

Frangin, Y

Mauclaire, L

Besnard, JC

Guilloteau, D

机构：

[1] CISBIOINT,SACLAY,FRANCE

[2] INSERM,U316,BIOPHYS LAB,F-37200 TOURS,FRANCE

来源：

JOURNAL OF NUCLEAR MEDICINE | 1997年 / 38卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：279 / 279

页数：1

共 48 条

[31] 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease
Koros, Christos
Simitsi, Athina
Prentakis, Andreas
Beratis, Ion
Papadimitriou, Dimitra
Kontaxopoulou, Dionysia
Fragkiadaki, Stella
Papagiannakis, Nikolaos
Seibyl, John
Marek, Kenneth
Papageorgiou, Sokratis G.
Trapali, Xenia Geronicola
Stamelou, Maria
Stefanis, Leonidas
MOVEMENT DISORDERS, 2018, 33 (11) : 1734 - 1739
[32] Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
Klivenyi, P
Gardian, G
Calingasan, NY
Yang, LC
Beal, MF
JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 21 (03) : 191 - 198
[33] Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease
Peter Klivenyi
Gabrielle Gardian
Noel Y. Calingasan
Lichuan Yang
M. Flint Beal
Journal of Molecular Neuroscience, 2003, 21 : 191 - 198
[34] Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease
Vaglini, F
Pardini, C
Viaggi, C
Bartoli, C
Dinucci, D
Corsini, GU
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (02) : 285 - 298
[35] Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson's disease
Kintz, Natalie
Petzinger, Giselle M.
Jakowec, Michael W.
NEUROREPORT, 2017, 28 (15) : 987 - 995
[36] Serotonin and dopamine depletion in distinct brain regions may cause anxiety in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice as a model of early Parkinson's disease
Yang, Ruixi
Ye, Suzhen
Zhang, Shuping
Huang, Hanjin
Zhang, Yun
Yang, Yao
Xie, Shu
He, Lin
Yang, Yuwei
Shi, Jian
NEUROREPORT, 2023, 34 (11) : 551 - 559
[37] Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray:: effect of R-apomorphine
Grünblatt, E
Mandel, S
Maor, G
Youdim, MBH
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (01) : 1 - 12
[38] Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson’s Disease
Xiaohong Wang
Lei Pang
Yanqing Zhang
Jiang Xu
Dongyi Ding
Tianli Yang
Qian Zhao
Fan Wu
Fei Li
Haiwei Meng
Duonan Yu
Neurochemical Research, 2018, 43 : 938 - 947
[39] Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease
Wang, Xiaohong
Pang, Lei
Zhang, Yanqing
Xu, Jiang
Ding, Dongyi
Yang, Tianli
Zhao, Qian
Wu, Fan
Li, Fei
Meng, Haiwei
Yu, Duonan
NEUROCHEMICAL RESEARCH, 2018, 43 (04) : 938 - 947
[40] Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Joniec, Ilona
Ciesielska, Agnieszka
Kurkowska-Jastrzebska, Iwona
Przybylkowski, Adam
Czlonkowska, Anna
Czlonkowski, Andrzej
BRAIN RESEARCH, 2009, 1261 : 7 - 19

← 1 2 3 4 5 →